Literature DB >> 16122567

Neuropsychologic assessment of frontal lobe dysfunction.

Elkhonon Goldberg1, Dmitri Bougakov.   

Abstract

Given the pervasive nature of executive deficit, assessment of executive functions is of crucial importance in neuropsychiatry, child and adolescent psychiatry, geriatric psychiatry, and other related areas. A number of neuropsychologic tests of executive function commonly are used in assessing several clinical disorders, including but not limited to traumatic brain injury, schizophrenia, depression, attention deficit disorder/attention deficit hyperactivity disorder, and dementia. Because the concept of executive control in its current form constitutes an over arching construct, a construct that is based on the cognitive symptoms of the frontal lobe disorder caused by many disparate underlying conditions, no single measure of executive function can adequately tap the construct in its entirety.Therefore, it is necessary to administer several tests of executive function,each assessing a particular aspect of the executive function. An appropriate combination of such neuropsychologic tests and batteries, including the Wisconsin Card Sorting Test, Tower test, Stroop test, the D-KEFS, and the ECB, provides an adequate but relatively crude mechanism for assessing executive systems dysfunction. Neuroscientists continue to refine their understanding of the nature of executive control, and additional innovative procedures that reflect state-of-the-art insights of cognitive neuroscience have been introduced recently. Among a few first steps in that direction are nonveridical, actor-centered procedures such as the CBT and the Iowa Gambling Test.

Entities:  

Mesh:

Year:  2005        PMID: 16122567     DOI: 10.1016/j.psc.2005.05.005

Source DB:  PubMed          Journal:  Psychiatr Clin North Am        ISSN: 0193-953X


  17 in total

Review 1.  Sick of sitting.

Authors:  James A Levine
Journal:  Diabetologia       Date:  2015-05-24       Impact factor: 10.122

2.  Impact of IQ discrepancy on executive function in high-functioning autism: insight into twice exceptionality.

Authors:  M Layne Kalbfleisch; Ashlee R Loughan
Journal:  J Autism Dev Disord       Date:  2012-03

3.  Executive resources.

Authors:  Rachel G Gross; Murray Grossman
Journal:  Continuum (Minneap Minn)       Date:  2010-08

4.  Development of a modified naturalistic action test for korean patients with impaired cognition.

Authors:  Mi Ae Jung; Hyun Jung Kim; Youn Joo Kang; Yon Joon Kim
Journal:  Ann Rehabil Med       Date:  2013-02-28

5.  Regional distribution and clinical correlates of white matter structural damage in Huntington disease: a tract-based spatial statistics study.

Authors:  R Della Nave; A Ginestroni; C Tessa; M Giannelli; S Piacentini; M Filippi; M Mascalchi
Journal:  AJNR Am J Neuroradiol       Date:  2010-05-20       Impact factor: 3.825

Review 6.  Neuroimaging and electrophysiological studies of the effects of acute tryptophan depletion: a systematic review of the literature.

Authors:  Paolo Fusar-Poli; Paul Allen; Philip McGuire; Anna Placentino; Mariachiara Cortesi; Jorge Perez
Journal:  Psychopharmacology (Berl)       Date:  2006-08-17       Impact factor: 4.530

7.  Early adolescent executive functioning, intrauterine exposures and own drug use.

Authors:  Ruth Rose-Jacobs; Shayna Soenksen; Danielle P Appugliese; Howard J Cabral; Mark A Richardson; Marjorie Beeghly; Timothy C Heeren; Deborah A Frank
Journal:  Neurotoxicol Teratol       Date:  2011-03-01       Impact factor: 3.763

Review 8.  The medial prefrontal cortex: coordinator of autonomic, neuroendocrine and behavioural responses to stress.

Authors:  J M McKlveen; B Myers; J P Herman
Journal:  J Neuroendocrinol       Date:  2015-06       Impact factor: 3.627

Review 9.  The diagnosis and treatment of individuals with mental illness and developmental disabilities: an overview.

Authors:  L Jarrett Barnhill
Journal:  Psychiatr Q       Date:  2008-09-03

10.  Meta-analysis of neuropsychological symptoms of adolescents and adults with PKU.

Authors:  J J Moyle; A M Fox; M Arthur; M Bynevelt; J R Burnett
Journal:  Neuropsychol Rev       Date:  2007-04-05       Impact factor: 7.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.